# Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer

> **NCT03580837** · — · UNKNOWN · sponsor: **University Hospital, Strasbourg, France** · enrollment: 100 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03580837
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03580837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03580837, "Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03580837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*